Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
ULTRALOQ Makes First Apple Home Key-Compatible Smart Lock 2025-08-05 23:00
Introducing VIOFO A329S 3CH with 2K Infrared Fisheye Cabin Camera -- Capture Both Inside & Out with Enhanced Clarity 2025-08-05 22:15
Luxury Look. Honest Price. OIWAS Bags Are Winning Over U.S. Consumers 2025-08-05 22:00
Sanyou Bio Wins the "2025 Best Customer Satisfaction CRO Award" 2025-08-05 22:00
BON Announces Reciept of Nasdaq Compliance Letter 2025-08-05 21:00
A Midsummer Night's Dream: Yaber, BLUETTI, and RayNeo Illuminate the Summer Outdoors 2025-08-05 21:00
FigureLabs: World's First AI scientific illustration tool for Effortless Publication Figures 2025-08-05 21:00
Beyond Music Acquires Copyright Catalog of Bekuh Boom, Hitmaker Behind BLACKPINK 2025-08-05 21:00
Breaking the Dirty Cycle: YEEDI's Self-Cleaning Mop Ushers in a New Cleaning Paradigm 2025-08-05 21:00
Recon Awarded Mega $5.85 Million Contract to Provide Upgrades Service for Large Mid-Asia Gas Field 2025-08-05 20:30
iNtRON Bio, Demonstrated Toxin-Neutralizing Effect of IMPA™ Phage Engineering Technology in Colorectal Cancer Model and Completed the US Patent Application 2025-08-05 20:00
Court Sides with Cardiovalve in Edwards patent spat 2025-08-05 20:00
Aurzen Redefines Portable Entertainment with BOOM air, a Searchlight-Style Projector Featuring Powerful Built-in Dolby Audio 2025-08-05 19:15
Multiplier Launches 'Beyond Borders' Series to Explore the Realities of Global Employment 2025-08-05 19:00
Ascletis Completes Enrollment in U.S. Phase IIa Study for Its Small Molecule Oral GLP-1R Agonist, ASC30, in Participants with Obesity or Overweight 2025-08-05 18:50
RLX Technology to Report Second Quarter 2025 Financial Results on August 22, 2025 2025-08-05 17:30
World Intelligent Vehicle Conference 2025 Successfully Concludes 2025-08-05 17:14
Yum China Board Welcomes New Board Member 2025-08-05 17:05
Yum China Reports Second Quarter 2025 Results 2025-08-05 17:00
Fapon Biopharma Announces the enrollment of the First Patient in the Phase I Clinical Trial of FP008, A First-in-Class Immunotherapy for Solid Tumors 2025-08-05 16:30
1 278 279 280 281 282 7156